Terns Pharmaceuticals
TERN
TERN
103 hedge funds and large institutions have $424M invested in Terns Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 93 → 103 (+10)
4.63% more ownership
Funds ownership: 101.05% → 105.68% (+4.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
103
Holding in Top 10
1
Calls
$1.58M
Puts
$249K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$9.25M | |
| 3 | +$9.12M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.17M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.31M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$3.39M | |
| 3 | -$3.17M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.87M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.68M |